Gut Microbes May Aid Autism Therapy

Faecal microbiota transplantation (FMT), a procedure involving the transfer of processed stool from a healthy donor to a patient, is emerging as a potential therapy for children with autism. This intervention aims to rebalance gut microbes, which research increasingly links to neurological and behavioral conditions. S. Hameed, a parent from Canada, reported significant improvements in her son's constipation, calmness, and eating habits after undergoing FMT at a Hyderabad research facility last September.

Experts like Dr. Chandrasekhar Thodupunuri highlight the gut-brain axis, noting that gut bacteria synthesize vital compounds such as serotonin and dopamine. These microbes can regulate mood, focus, and social behavior, and fermenting dietary fibers can protect the brain and reduce inflammation. Disruptions in gut microbiota are thought to influence neurological conditions like autism, with children often experiencing gastrointestinal issues that affect their quality of life and behavior.

While preliminary observations from a Hyderabad center suggest improvements in gut health for about 56 children, medical professionals caution that evidence is limited. Dr. Nitin Chawla stresses that autism is multifactorial, and while FMT shows potential benefits in some cases, robust scientific scrutiny is essential before clinical adoption. Potential risks, such as infection from improper donor screening, also warrant careful consideration. Further research is also exploring environmental factors, like agrochemical exposure during pregnancy, as possible influences on brain development and gut microbiota.